The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Chromadex Corp shares valued at $229,956 were sold by Jaksch Frank L Jr on Dec 13 ’24. At $6.19 per share, Jaksch Frank L Jr sold 37,161 shares. The insider’s holdings dropped to 244,179 shares worth approximately $1.39 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Frank Jaksch Jr. purchased 37,161 shares, netting a total of over 229,961 in proceeds.
Before that, Pamir Ozan had added 2,907 shares to its account. In a trade valued at $21,397, the Chief Financial Officer bought Chromadex Corp shares for $7.36 each. Upon closing the transaction, the insider’s holdings increased to 2,907 shares, worth approximately $16569.9.
As published in a research note from Oppenheimer on August 16, 2022, Chromadex Corp [CDXC] has been rated down from an Outperform to a Perform. Analysts at B. Riley Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid August. As of March 08, 2022, ROTH Capital has initiated its “Buy” rating for CDXC. Earlier on October 16, 2019, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for CDXC stock.
Analyzing CDXC Stock Performance
During the last five days, there has been a drop of approximately -11.63%. Over the course of the year, Chromadex Corp shares have jumped approximately 298.60%. Shares of the company reached a 52-week high of $7.97 on 11/29/24 and a 52-week low of $1.36 on 01/23/24. A 50-day SMA is recorded $5.73, while a 200-day SMA reached $3.82. Nevertheless, trading volume fell to 0.65 million shares from 0.66 million shares the previous day.
Support And Resistance Levels for Chromadex Corp (CDXC)
According to the 24-hour chart, there is a support level at 5.53, which, if violated, would cause prices to drop to 5.35. In the upper region, resistance lies at 5.96. The next price resistance is at 6.22. RSI (Relative Strength Index) is 35.57 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.76, which suggests the price will decrease in the coming days. Percent R is at 96.40%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
